Atherogenesis in human - clinical aspects of circulating immune complexes

Author:

Babintseva Yanina D.1,Sergeeva A. M.2,Karagodin V. P.3,Orekhov A. N.4

Affiliation:

1. N.I. Pirogov Russian National Research Medical University

2. Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences

3. G.V. Plekhanov Russian University of Economics

4. Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences; Institute for Atherosclerosis Research, Skolkovo Innovative Center

Abstract

It has been suggested that circulating immune complexes containing low density lipoproteins (LDL-CIC) play a role in atherogenesis and are involved in the formation of early atherosclerotic lesions. The complexes, as well as anti-LDL antibody were found in the blood of patients with atherosclerotic process in various cardiovascular diseases, well as in the blood of animals with experimentally modulated atherosclerosis. One can assume that the presence anti-LDL antibodies in blood is a result of an immune response that is induced by modification of lipoproteins. LDL-CIC differ from native LDL in many aspects. They have much lower levels of sialic acid, a smaller diameter and a higher density electronegativity than native LDL. The fraction of the LDL-CIC in serum is an important manifestation of the atherosclerotic process. LDL-CIC, unlike the native LDL is able to induce intracellular accumulation of neutral lipids, especially esterified cholesterol in cell cultures obtained from healthy human aortic intima and macrophages in culture. After removal of the LDL-CIC, the serum of CHD-patients loses its atherogenic properties. The titer of the LDL-CIC in the blood serum significantly correlate with the progression of atherosclerosis and in vivo has the highest diagnostic yield of measured among other lipid parameters. Increasing CIC- cholesterol could also increase the risk of coronary artery atherosclerosis.

Publisher

Medical Informational Agency Publishers

Subject

General Medicine

Reference60 articles.

1. Feoktistov A.S., Gavrilin M.A., Karagodin V.P., Bobryshev Yu.V., Orekhov A.N. Promising therapeutic approaches to inhibition of atherogenic modification (desialic) LDL. Patogenez. 2013; 11 (2): 46—50 (in Russian)

2. Aksenov D.V., Medvedeva L.A., Skalbe T.A., Sobenin I.A., Tertov V.V., Gabbasov Z.A. et al. Deglycosylation of apo B-containing lipoproteins increase their ability to aggregate and to promote intracellular cholesterol accumulation in vitro. Arh. Fiziol. Biohim. 2008; 114 (5): 349—56 (in Russian)

3. Borodachev E.N., Sobenin I.A., Karagodin V.P., Bobryshev Yu.V., Orekhov A.N. Multiple modification of low density lipoproteins in diabetes mellitus. Patogenez. 2013, 11 (4): 16—21. (in Russian)

4. Orekhov A.N. Mechanisms of atherogenesis and development of antiatherosclerotic therapy. Curr. Pharm. 2015; 21 (9): 1103—6.

5. Mel'nichenko А.А., Orekhova V.А., Sobenin I.A., Karagodin V.P., Orekhov A.N. The development of cellular models to assess the reverse cholesterol transport. Patogenez. 2013; 11 (4): 39—48 (in Russian)

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3